SeaBird Exploration Plc
22 January 2021, Limassol, Cyprus
SeaBird Exploration Plc (“The Company”) announces today that it has agreed to sell a total of 100,500 shares in Green Minerals AS to several buyers at a price of NOK 20 per share. Following the sale of shares SeaBird Exploration Plc owns 76.8% of the shares in Green Minerals AS.
The Company has decided to meet the interest from these buyers in the market place, but do not intend to sell any further shares in Green Minerals AS before the planned listing in Q1 this year. The Company anticipates that the application to Euronext Growth Oslo will be filed shortly and that the earlier communicated time schedule for a listing in Q1 2021 will be met. The cut-off date for the announced distribution of shares in Green Minerals AS to SeaBird`s shareholders will be announced as soon as the Company receives the approval by the Registrar in Cyprus.
For further queries contact:
Erik von Krogh
CFO
Mob: +47 930 38 075
All statements in this press release other than statements of historical fact are forward-looking statements and are subject to a number of risks, uncertainties and assumptions that are difficult to predict, and are based upon assumptions as to future events that may not prove accurate. These factors include SeaBird`s reliance on a cyclical industry and the utilization of the company's vessels. Actual results may differ substantially from those expected or projected in the forward-looking statements.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Robex Resources Inc.18.9.2025 08:01:56 CEST | Press release
Robex Announces Acceleration of Warrant Expiry Date
ONWARD Medical NV18.9.2025 07:30:00 CEST | Press release
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
Sampo plc18.9.2025 07:30:00 CEST | Press release
Sampo plc’s share buybacks 17 September 2025
Biotalys NV18.9.2025 07:00:00 CEST | Press release
Biotalys Reports Half-Year 2025 Financial Results and Business Highlights
F. Hoffmann-La Roche Ltd18.9.2025 07:00:00 CEST | Press release
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom